Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior

Journal of Neuroscience

Volumn 30, Issue 6, 2010, Pages 2300-2310

  Plaza Zabala, Ainhoa ^a   Martín García, Elena ^a   De Lecea, Luis ^b   Maldonado, Rafael ^a   Berrendero, Fernando ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; ANTALARMIN; ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; NEUROPEPTIDE; NICOTINE; OREXIN; OREXIN 1 RECEPTOR; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; FOOTSHOCK; GENE DELETION; HYPOTHALAMUS; HYPOTHALAMUS NUCLEUS; MALE; MAZE TEST; MOUSE; NERVE CELL; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; STRESS; THALAMUS MIDLINE NUCLEUS; TOBACCO DEPENDENCE; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; ARGININE VASOPRESSIN; BEHAVIOR, ADDICTIVE; BENZOXAZOLES; CONDITIONING, OPERANT; CORTICOTROPIN-RELEASING HORMONE; EXTINCTION, PSYCHOLOGICAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; NEUROPEPTIDES; NICOTINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PYRIMIDINES; PYRROLES; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; SELF ADMINISTRATION; TOBACCO USE DISORDER; UREA;

EID: 76649130906     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5724-09.2010     Document Type: Article

References (64)

1. Aston-Jones G, Smith RJ, Sartor GC, Moorman DE, Massi L, Tahsili-Fahadan P, Richardson KA (2009) Lateral hypothalamic orexin/hypocretin neurons: a role in reward-seeking and addiction. Brain Res. Advance online publication. Retrieved October 7, 2009. doi:10.1016/j.brainres.2009.09.106.
2. Bäckberg M, Hervieu G, Wilson S, Meister B (2002) Orexin receptor-1 (OX-R1) immunoreactivity in chemically identified neurons of the hypothalamus: focus on orexin targets involved in control of food and water intake. Eur J Neurosci 15:315-328.
3. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R (2004) Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20:2737-2748.
4. Balerio GN, Aso E, Maldonado R (2005) Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 181:260-269.
5. Berrendero F, Mendizábal V, Robledo P, Galeote L, Bilkei-Gorzo A, Zimmer A, Maldonado R (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the pre-proenkephalin gene. J Neurosci 25:1103-1112.
6. Bilkei-Gorzo A, Rácz I, Michel K, Darvas M, Maldonado R, Zimmer A (2008) A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol Psychiatry 63:164-171.
7. Bonci A, Borgland S (2009) Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 56 (Suppl 1):107-111.
8. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A (2006) Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49:589-601.
9. Borgland, SL, Ungless MA, Bonci A (2009) Convergent actions of orexin/ hypocretin and CRF on dopamine neurons: emerging players in addiction. Brain Res. Advance online publication. Retrieved November 4, 2009. doi:10.1016/j. brainres.2009.10.068.
10. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, de Lecea L (2005) Role for hypocretin in mediating stress-induced rein-statement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102:19168-19173.
11. Bruijnzeel AW, Prado M, Isaac S (2009) Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol Psychiatry 66:110-117.
12. Chemelli RM, Willie JT, Sinton CM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M (1999) Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98:437-451.
13. Cohen S, Lichtenstein E (1990) Perceived stress, quitting smoking, and smoking relapse. Health Psychol 9:466-478.
14. Cooper JO, Heron TE, Heward WL (1987) Applied behavior analysis. New York: Macmillan.
15. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, Fukuhara C, Battenberg EL, Gautvik VT, Bartlett FS 2nd, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG (1998) The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95:322-327.
16. de Lecea L, Jones BE, Boutrel B, Borgland SL, Nishino S, Bubser M, DiLeone R (2006) Addiction and arousal: alternative roles of hypothalamic peptides. J Neurosci 26:10372-10375.
17. Dravolina OA, Zakharova ES, Shekunova EV, Zvartau EE, Danysz W, Bespalov AY (2007) mGlu1 receptor blockade attenuates cue- and nicotine-induced reinstatement of extinguished nicotine self-administration behavior in rats. Neuropharmacology 52:263-269.
18. File SE, Cheeta S, Kenny PJ (2000) Neurobiological mechanisms by which nicotine mediates different types of anxiety. Eur J Pharmacol 393:231-236.
19. Follwell MJ, Ferguson AV (2002) Cellular mechanisms of orexin actions on paraventricular nucleus neurones in rat hypothalamus. J Physiol 545:855-867.
20. Foulds J, Stapleton JA, Bell N, Swettenham J, Jarvis MJ, Russell MA (1997) Mood and physiological effects of subcutaneous nicotine in smokers and never-smokers. Drug Alcohol Depend 44:105-115.
21. Funk D, Li Z, Lê AD (2006) Effects of environmental and pharmacological stressors on c-fos and corticotropin-releasing factor mRNA in rat brain: relationship to the reinstatement of alcohol seeking. Neuroscience 138:235-243.
22. Harris GC, Aston-Jones G (2006) Arousal and reward: a dichotomy in orexin function. Trends Neurosci 29:571-577.
23. Harris GC, Wimmer M, Aston-Jones G (2005) A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437:556-559.
24. Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G (2007) Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res 183:43-51.
25. Hollander JA, Lu Q, Cameron MD, Kamenecka TM, Kenny PJ (2008) Insular hypocretin transmission regulates nicotine reward. Proc Natl Acad Sci U S A 105:19480-19485.
26. Hsu HR, Chen TY, Chan MH, Chen HH (2007) Acute effects of nicotine on restraint stress-induced anxiety-like behavior, c-Fos expression, and corticosterone release in mice. Eur J Pharmacol 566:124-131.
27. Kassel JD, Unrod M (2000) Smoking, anxiety, and attention: support for the role of nicotine in attentionally mediated anxiolysis. J Abnorm Psychol 109:161-166.
28. Kovács KJ (2008) Measurement of immediate-early gene activation c-fos and beyond. J Neuroendocrinol 20:665-672.
29. Landgraf R (2005) Neuropeptides in anxiety modulation. Handb Exp Pharmacol 169:335-369.
30. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006) The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148:752-759.
31. Lightman SL (2008) The neuroendocrinology of stress: a never ending story. J Neuroendocrinol 20:880-884.
32. Loughlin SE, Islas MI, Cheng MY, Lee AG, Villegier AS, Leslie FM (2006) Nicotine modulation of stress-related peptide neurons. J Comp Neurol 497:575-588.
33. Lutfy K, Brown MC, Nerio N, Aimiuwu O, Tran B, Anghel A, Friedman TC (2006) Repeated stress alters the ability of nicotine to activate the hypothalamic-pituitary-adrenal axis. J Neurochem 99:1321-1327.
34. Martín-García E, Barbano MF, Galeote L, Maldonado R (2009) New operant model of nicotine-seeking behaviour in mice. Int J Neuropsychopharmacol 12:343-356.
35. McLellan AT, Lewis DC, O'Brien CP, Kleber HD (2000) Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 284:1689-1695.
36. Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakurai T, Scammell TE (2004) Behavioral state instability in orexin knock-out mice. J Neurosci 24:6291-6300.
37. Nair SG, Golden SA, Shaham Y (2008) Differential effects of the hypocretin 1 receptor antagonist SB334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol 154:406-416.
38. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, Sakurai T, Yanagisawa M, Nakamachi T, Shioda S, Suzuki T (2006) Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci 26:398-405.
39. Newhouse PA, Sunderland T, Narang PK, Mellow AM, Fertig JB, Lawlor BA, Murphy DL (1990) Neuroendocrine, physiologic, and behavioral responses following intravenous nicotine in nonsmoking healthy volunteers and in patients with Alzheimer's disease. Psychoneuroendocrinology 15:471-484.
40. Pañeda C, Huitron-Resendiz S, Frago LM, Chowen JA, Picetti R, de Lecea L, Roberts AJ (2009) Neuropeptide S reinstates cocaine-seeking behavior and increases locomotor activity through corticotrophin-releasing factor receptor 1 in mice. J Neurosci 29:4155-4161.
41. Parrott AC (1995) Stress modulation over the day in cigarette smokers. Addiction 90:233-244.
42. Pasumarthi RK, Reznikov LR, Fadel J (2006) Activation of orexin neurons by acute nicotine. Eur J Pharmacol 535:172-176.
43. Paxinos G, Franklin KBJ (1997) The mouse brain in stereotaxic coordinates. San Diego: Academic.
44. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998) Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015.
45. Picciotto MR, Zoli M, Rimondini R, Léna C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391:173-177.
46. Pomerleau OF (1986) Nicotine as a psychoactive drug: anxiety and pain reduction. Psychopharmacol Bull 22:865-869.
47. Richards JK, Simms JA, Steensland P, Taha SA, Borgland SL, Bonci A, Bartlett SE (2008) Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats. Psychopharmacology (Berl) 199:109-117.
48. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, Upton N, Porter RA, Johns A, Blundell JE (2001) SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci 13:1444-1452.
49. Sakamoto F, Yamada S, Ueta Y (2004) Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central amygdaloid nucleus of rats: possible involvement of central orexins on stress-activated central CRF neurons. Regul Pept 118:183-191.
50. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573-585.
51. Samson WK, Taylor MM, Follwell M, Ferguson AV (2002) Orexin actions in hypothalamic paraventricular nucleus: physiological consequences and cellular correlates. Regul Pept 104:97-103.
52. Shalev U, Erb S, Shaham Y (2009) Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res. Advance online publication. Retrieved July 24, 2009. doi:10.1016/j.brainres.2009.07.028.
53. Sharf R, Sarhan M, DiLeone RJ (2009) Role of orexin/hypocretin in dependence and addiction. Brain Res. Advance online publication. Retrieved August 21, 2009. doi:10.1016/j.brainres.2009.08.028.
54. Shirasaka T, Miyahara S, Kunitake T, Jin QH, Kato K, Takasaki M, Kannan H (2001) Orexin depolarizes rat hypothalamic paraventricular nucleus neurons. Am J Physiol Regul Integr Comp Physiol 281:R1114-R1118.
55. Shram MJ, Funk D, Li Z, Lê AD (2007) Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain. Neurosci Lett 418:286-291.
56. Singewald N, Salchner P, Sharp T (2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53:275-283.
57. Soria G, Mendizábal V, Touriño C, Robledo P, Ledent C, Parmentier M, Maldonado R, Valverde O (2005) Lack of CB1 cannabinoid receptor impairs cocaine self-administration. Neuropsychopharmacology 30:1670-1680.
58. Thomsen M, Caine SB (2007) Intravenous drug self-administration in mice: practical considerations. Behav Genet 37:101-118.
59. Valentine JD, Matta SG, Sharp BM (1996) Nicotine-induced cFos expression in the hypothalamic paraventricular nucleus is dependent on brainstem effects: correlations with cFos in catecholaminergic and noncatecholaminergic neurons in the nucleus tractus solitarius. Endocrinology 137:622-630.
60. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB (2005) Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25:5389-5396.
61. Wang B, You ZB, Wise RA (2009) Reinstatement of cocaine seeking by hypocretin (orexin) in the ventral tegmental area: independence from the local corticotropin-releasing factor network. Biol Psychiatry 65:857-862.
62. Winsky-Sommerer R, Yamanaka A, Diano S, Borok E, Roberts AJ, Sakurai T, Kilduff TS, Horvath TL, de Lecea L (2004) Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24:11439-11448.
63. Winsky-Sommerer R, Boutrel B, de Lecea L (2005) The corticotrophin- releasing factor/hypocretin circuitry. Mol Neurobiol 32:285-294.
64. Zislis G, Desai TV, Prado M, Shah HP, Bruijnzeel AW (2007) Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 53:958-966.